Asset Value Investors Limited (“AVI”) today announced an update to its public campaign regarding Rohto Pharmaceutical Co., ...

Phase 2b top-line data from EVO756 in chronic spontaneous urticaria (CSU) and atopic dermatitis (AD) on track for June 2026 ...

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, ...

Conference Call Begins at 4:30 p.m. Eastern Time TodayEMERYVILLE, Calif.--(BUSINESS WIRE)--$OABI #OABI--OmniAb, Inc. (NASDAQ: ...

Raising 2026 Revenue and Net Income Guidance Based on Increased Demand for NERLYNXLOS ANGELES--(BUSINESS WIRE)--Puma ...

Veteran trial lawyer honored on 2026 list for excellence in mass tortsDALLAS--(BUSINESS WIRE)--Ben C. Martin, founding partner of the elite personal injury law firm Ben Martin Law Group, has been ...

Scientific research will highlight advances in dry powder inhaler (DPI) platform products, patient-centric design and ...

U.S. net sales of $273 million in Q1 2026, primarily driven by improved net price and 5% EUTRx demand growth year-over-year – ...

New 4-year longitudinal data from the Phase 1/2a open-label extension (OLE) studies provide additional support for the ...

Product Sales Excluding Veklury Increased 8% Year-Over-Year to $6.8 billionBiktarvy Sales Increased 7% Year-Over-Year to $3.4 billionFOSTER CITY, Calif.--(BUSINESS WIRE)--#Earnings--Gilead Sciences, ...

Publication in Science magazine outlines blueprint for the scalable synthesis of complex orally available macrocyclic peptidesEnlicitide, a novel macrocyclic peptide, has the potential to be the first ...

Conference Call and Webcast Today, May 7, 2026, at 4:30 p.m. ETPASADENA, Calif.--(BUSINESS WIRE)--$arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal ...